Table 2. Antibiotic susceptibility profile of clinical vancomycin resistant Enterococci (VRE) isolates from Caribbean countries, 2009–2014 (%).
Antimicrobial agent | E. faecium | E. faecalis | ||
---|---|---|---|---|
Sensitive | Resistant | Sensitive | Resistant | |
Ampicillin | 5 (7.1) | 65 (92.8) | 0 | 7 (100) |
Chloramphenicol | 15 (21.4 | 55 (78.6) | 2 (28.6) | 5 (71.4) |
Ciprofloxacin | 0 | 70 (100) | 0 | 7 (100) |
Daptomycin | 70 (100) | 0 | 7 (100) | 0 |
Erythromycin | 0 | 70 (100) | 0 | 7 (100) |
Gentamicin | 65 (92.8) | 5 (7.2) | 4 (57.1) | 3 (42.9) |
Levofloxacin | 5 (7.1) | 65 (92.9) | 0 | 7 (100) |
Linezolid | 70 (100) | 0 | 7 (100) | 0 |
Penicillin | 0 | 70 (100) | 0 | 7 (100) |
Quinuprustin/Dalfopristin | 70 (100) | 0 | 7 (100) | 0 |
Streptomycin | 45 (64.3) | 25 (35.7) | 5 (71.4) | 2 (28.6) |
Tetracycline | 25 (35.7) | 45 (64.3) | 0 | 7 (100) |
Teicoplanin | 70 (100) | 0 | 7 (100) | 0 |
Tigecycline | 70 (100) | 0 | 7 (100) | 0 |
Vancomycin | 0 | 70 (100) | 0 | 7 (100) |